chr2-208128371-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_020989.4(CRYGC):c.357C>T(p.Ser119=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00242 in 1,614,150 control chromosomes in the GnomAD database, including 83 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.013 ( 34 hom., cov: 33)
Exomes 𝑓: 0.0014 ( 49 hom. )
Consequence
CRYGC
NM_020989.4 synonymous
NM_020989.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.51
Genes affected
CRYGC (HGNC:2410): (crystallin gamma C) This gene encodes a member of the beta/gamma-crystallin family of proteins. Crystallins constitute the major proteins of vertebrate eye lens and maintain the transparency and refractive index of the lens. This gene and several family members are present in a gene cluster on chromosome 2. Mutations in this gene have been shown to cause multiple types of cataract, including Coppock-like cataract and zonular pulverulent cataract, among others. [provided by RefSeq, Jan 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 2-208128371-G-A is Benign according to our data. Variant chr2-208128371-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 465774.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-208128371-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-1.51 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0126 (1914/152258) while in subpopulation AFR AF= 0.0431 (1792/41538). AF 95% confidence interval is 0.0415. There are 34 homozygotes in gnomad4. There are 935 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1914 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CRYGC | NM_020989.4 | c.357C>T | p.Ser119= | synonymous_variant | 3/3 | ENST00000282141.4 | |
LOC100507443 | NR_038437.1 | n.98-8685G>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CRYGC | ENST00000282141.4 | c.357C>T | p.Ser119= | synonymous_variant | 3/3 | 1 | NM_020989.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0125 AC: 1901AN: 152140Hom.: 33 Cov.: 33
GnomAD3 genomes
AF:
AC:
1901
AN:
152140
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00340 AC: 854AN: 251428Hom.: 18 AF XY: 0.00249 AC XY: 338AN XY: 135898
GnomAD3 exomes
AF:
AC:
854
AN:
251428
Hom.:
AF XY:
AC XY:
338
AN XY:
135898
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00136 AC: 1990AN: 1461892Hom.: 49 Cov.: 31 AF XY: 0.00120 AC XY: 874AN XY: 727248
GnomAD4 exome
AF:
AC:
1990
AN:
1461892
Hom.:
Cov.:
31
AF XY:
AC XY:
874
AN XY:
727248
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0126 AC: 1914AN: 152258Hom.: 34 Cov.: 33 AF XY: 0.0126 AC XY: 935AN XY: 74434
GnomAD4 genome
AF:
AC:
1914
AN:
152258
Hom.:
Cov.:
33
AF XY:
AC XY:
935
AN XY:
74434
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
16
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 06, 2020 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Nuclear pulverulent cataract Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 13, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at